Dynamic Technology Lab Private LTD Beam Therapeutics Inc. Transaction History

Dynamic Technology Lab Private LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$23.46 - $45.07 $308,076 - $591,859	13,132 Added 76.96%	30,196 $998,000
Q4 2023 Feb 09, 2024	BUY	$17.69 - $30.76 $301,862 - $524,888	17,064 New	17,064 $464,000
Q2 2022 Aug 12, 2022	SELL	$29.86 - $62.36 $518,668 - $1.08 Million	-17,370 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$53.73 - $82.16 $933,290 - $1.43 Million	17,370 New	17,370 $995,000
Q4 2021 Feb 14, 2022	SELL	$68.02 - $99.06 $180,729 - $263,202	-2,657 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$84.37 - $133.6 $41,088 - $65,063	487 Added 22.44%	2,657 $231,000
Q2 2021 Aug 13, 2021	SELL	$64.12 - $128.71 $99,642 - $200,015	-1,554 Reduced 41.73%	2,170 $279,000
Q1 2021 May 14, 2021	BUY	$71.28 - $120.75 $265,446 - $449,673	3,724 New	3,724 $298,000

236

75.2M

438K

232K

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.78B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.